Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College announced Oct. 1 that they have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) and have partnered with Takeda Pharmaceutical Company, Ltd. (TSE:4502).
We’ve updated our Privacy Policy to make it clearer how we use your personal data.
Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.